Related Experiment Video
Updated: Dec 10, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Valvular Heart Disease in Pregnancy: Anticoagulation and the Role of Percutaneous Treatment
Rahul Gupta1, Aaqib H Malik2, Purva Ranchal3
1Lehigh Valley Heart Institute, Lehigh Valley Health Network, Allentown, PA.
Abstract:
Valvular heart disease is present in about 1% of pregnancies, and it poses a management challenge as both fetal and maternal lives are at risk of complications. Pregnancy is associated with significant hemodynamic changes, which can compromise the cardiac status in women with underlying valvular disorders. Management of valvular heart diseases has undergone considerable innovation and advancement with newer techniques, approaches and devices being employed. The decision regarding the management of anticoagulation, especially in patients with prosthetic valves, raises distinct questions and challenges. In this review, we describe the management of common valvular heart diseases encountered during pregnancy, role of percutaneous catheter based therapeutic interventions, the importance of a team-based approach, and the challenges given existing gaps in the literature.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Mitral Valve Prolapse III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins

